capecitabine
not tagged
['#gi', 'rectal']
#asco22 #asco2022 #gioncology tautem study: non-inferiority rct for t2 and superficial t3 rectal cancer local excision versus tme. superficial=less than 5 mm into mesorectum max diameter of 4 cm primary endpoint: 2 year local recurrence rate
Stanford Oncologist || BYU alum || Penn Med alum || author || American Studies amateur || religious studies amateur || podcasting @ https://t.co/KnVbI8oZ43